| AVUGX | VIVIX | AVUGX / VIVIX | |
| Total Expense Ratio | 0.75 | 0.03 | 2,500% |
| Annual Report Gross Expense Ratio | 0.78 | 0.03 | 2,600% |
| Fund Existence | 9 years | 28 years | - |
| Gain YTD | 14.140 | 14.777 | 96% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.93B | 245B | 1% |
| Annual Yield % from dividends | 1.55 | 1.88 | 83% |
| Returns for 1 year | 14.59 | 22.78 | 64% |
| Returns for 3 years | 23.00 | 54.03 | 43% |
| Returns for 5 years | 4.49 | 58.49 | 8% |
| Returns for 10 years | N/A | 158.70 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FSCHX | 14.68 | 0.19 | +1.31% |
| Fidelity Select Chemicals | |||
| MFWLX | 17.93 | 0.19 | +1.07% |
| MFS Global Total Return R6 | |||
| GIDWX | 19.93 | 0.02 | +0.10% |
| Goldman Sachs US Eq Div and Premium R6 | |||
| BSPIX | 869.44 | 0.03 | N/A |
| iShares S&P 500 Index Institutional | |||
| TRCLX | 19.10 | -0.80 | -4.02% |
| T. Rowe Price China Evolution Equity I | |||